Previous Close | 14.20 |
Open | 14.20 |
Bid | 4.40 |
Ask | 11.95 |
Strike | 490.00 |
Expire Date | 2025-06-20 |
Day's Range | 14.20 - 14.20 |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
Structure Therapeutics stock roses sharply Monday after the biotech company delivered "compelling" results for its weight-loss drug.
Eli Lilly, T-Mobile US, BHP, American International and Exelon are part of the Zacks Analyst Blog.
Eli Lilly, Novo Nordisk, Vertex Pharmaceuticals, Intuitive Surgical and Universal Health are all trading in or near buy zones. Medical stocks are often viewed as defensive growth stocks, because their growth is insulated from economic swings due to the government or insurance covering most of the costs. Eli Lilly is in a buy zone while weight-loss drug rival and fellow IBD Leaderboard member Novo Nordisk is setting up.